AstraZeneca PLC is 141.9x more valuable than Trevi Therapeutics, Inc. by market capitalization ($286.27 B vs $2.02 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TRVI | AZN |
|---|---|---|
| Market cap | $2.02 B | $286.27 B |
| US-listed rank | #2107 | #49 |
| Net income (latest FY) | -$42.76M | - |
| SEC filings | 524 | 1,004 |
AstraZeneca PLC is 141.9x more valuable than Trevi Therapeutics, Inc. by market capitalization ($286.27 B vs $2.02 B).
Full pages: Trevi Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.